Universal Health Services Sets 2026 Executive Compensation with Enhanced Performance Metrics
Universal Health Services (NYSE: UHS) has established its 2026 executive compensation structure, featuring target bonuses ranging from 100% to 150% of base salaries and a significant shift in how the company measures long-term performance incentives, according to an SEC filing on March 30, 2026.
The Change
The healthcare giant's Compensation Committee approved annual incentive bonuses and long-term stock awards for its executive team on March 26, 2026. CEO Marc D. Miller leads with a target bonus of 150% of base salary, while other executives including CFO Steve G. Filton and division presidents Edward H. Sim and Matthew J. Peterson each have 100% targets.
A notable change in the compensation structure involves the performance-based restricted stock units (PBRSUs). Starting with the 2026 grants, UHS will measure performance based on three-year average results rather than solely on third-year aggregate performance. Additionally, the maximum payout potential for exceeding performance targets has increased from 150% to 200% of target awards.
The executive team received both time-based restricted stock units (RSUs) and PBRSUs valued at $185.09 per share. CEO Marc Miller received 29,715 RSUs and an equal number of PBRSUs at target, representing the largest grant. Executive Chairman Alan B. Miller received 14,153 of each, while other executives received between 5,627 and 6,850 units.
Background
Universal Health Services operates one of the largest hospital networks in the United States, with divisions spanning acute care and behavioral health services. The company's executive compensation structure ties leadership rewards directly to corporate and divisional performance metrics.
For 2026, bonuses will be determined based on adjusted net income per diluted share and return on capital metrics. The CEO and CFO will have 100% of their bonuses tied to corporate performance, while division presidents Sim and Peterson will have a 25/75 split between corporate and divisional income targets.
The shift to three-year average performance measurement for PBRSUs aligns UHS with peer company practices, according to recommendations from the company's third-party compensation consultant. Performance thresholds range from 90% of target Adjusted EBITDA (earning 50% payout) to 110% or greater (earning the new 200% maximum payout).
Executive Chairman Alan B. Miller also received a $1.07 million discretionary cash bonus for 2025 performance, separate from the 2026 incentive structure.
What It Means
The enhanced compensation structure signals UHS's confidence in sustained growth over multiple years rather than single-year performance spikes. By moving to three-year average metrics, the company reduces the impact of annual volatility while maintaining high performance standards.
The increased maximum payout from 150% to 200% for exceeding targets suggests the board wants to more aggressively reward exceptional performance. This could incentivize management to pursue strategies that deliver consistent above-target results rather than merely meeting baseline expectations.
For the acute care and behavioral health divisions, the 75% weighting on divisional performance ensures executives remain focused on their specific operating segments while maintaining alignment with overall corporate objectives through the 25% corporate performance component.
The four-year vesting schedule for RSUs provides retention incentives, while the performance-based awards ensure executives have skin in the game for delivering measurable financial results. With healthcare facing ongoing regulatory changes and reimbursement pressures, this balanced approach aims to retain top talent while demanding operational excellence.
The compensation committee's reliance on third-party consultant recommendations and alignment with peer practices demonstrates governance discipline, particularly important for a company operating in the heavily regulated healthcare sector where executive compensation often faces scrutiny.
*Source: Universal Health Services Form 8-K filed with the SEC on March 30, 2026*
*StockCliff Research*